Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “EUPHORIA”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 55 records · Page 3Linked to original sources
PubMed1986

Evaluation of tilidine for morphine-like subjective effects and euphoria.

Tilidine is an opioid analgesic that has been abused predominantly by the oral route. Studies of parenterally administered tilidine in animals did not clearly indicate a dependence potential of the morphine type. In this study we examined the abuse potential of orally and parenterally administered tilidine in humans. Both orally and intramuscularly given tilidine produced miosis and morphine-like subjective effects in non-dependent subjects. Oral tilidine was 1/8-1/10 as potent and intramuscular tilidine was 1/22 as potent as parenteral morphine in producing morphine-like subjective and miotic effects. Intramuscular tilidine suppressed and did not precipitate signs of abstinence in morphine-dependent subjects. However, intramuscularly given tilidine produced toxic effects not seen with morphine. Meperidine, codeine and d-propoxyphene produced morphine-like subjective and miotic effects, but also produced toxic effects at the highest doses tested. The results suggest that tilidine has a potential to be abused, that this potential is less than that of parenteral morphine and that tilidine is more likely to be abused orally than by the intramuscular route.

Administration, Oral↗
PubMed1994

Mood-moderating effects of affect intensity on cognition: sometimes euphoria is not beneficial and dysphoria is not detrimental.

Affect intensity (AI) is a characteristic of temperament that has been hypothesized to moderate the influence of mood on cognitive processing. To test predictions concerning this interaction, 132 women were divided into groups of high and low AI and received positive, neutral, or negative mood inductions. They then engaged in either a self-generated or didactic learning task, and the effects of mood and AI on recall and recognition performance were assessed. Consistent with predictions, positive mood led to poorer performance for high AI relative to low AI individuals, and negative mood resulted in a converse pattern of outcomes. The results are discussed with reference to implications for the AI construct and mood-induction research.

Adaptation, Psychological↗
PubMedDate not supplied

Alcohol-induced euphoria: exclusion of serotonin.

During the first 30 min after acute ethanol consumption by three fasting normal male volunteers, no increase in circulating tryptophan availability to the brain occurred. On the contrary, a small decrease was observed, which became stronger subsequently. We conclude from this preliminary study that brain serotonin levels are not increased after alcohol intake by normal subjects and that, consequently, this indolylamine is unlikely to mediate the euphoric effects of alcohol.

Adult↗
PubMed1996

Methylphenidate euphoria.

Explore the source record for details and available documents.

Attention Deficit Disorder with Hyperactivity↗
PubMed2004

After the euphoria: HIV medical technologies from the perspective of their prescribers.

This paper focuses on the relationship of HIV medical technologies to current styles of medical practice and highlights issues posed by the technologies for those working and/or living with HIV. The paper examines HIV anti-retroviral combination therapies and associated tests from the perspective of their prescribers. The prescribers were interviewed during the later part of 2002 at three London HIV clinics. Their comments, considered in light of other recent studies in the field, suggest that current therapies are part of a transitional phase in the epidemic which informs the identification and negotiation of known risks and uncertainty. An undetermined but extended life expectancy, afforded by anti-retroviral therapies, is understood against risk of iatrogenic diseases and/or viral drug resistance. The tension arising in this situation of unwanted and even uncertain phenomena poses ethical dilemmas and affects doctor/patient relations. Indeed, it also contributes to a reconfiguring of the lived experience of managing HIV. While the new technologies have offered considerable advances in the medical management of HIV, they are altering the nature of HIV medicine both materially and socially. The scenario is further complicated by the uneven allocation of resources and different patient health and disease states. The heterogeneity of resources, disease states and technological effects points to the need for ongoing and extended evaluation as the relationship between these and the everyday practice of medicine continues to change.

Antiretroviral Therapy, Highly Active↗
PubMed2005

Postnatal euphoria: are 'the highs' an indicator of bipolarity?

Research into postnatal mood disorders to date has concentrated on depressive syndromes of varying severity and full-blown acute puerperal mania. However, clinical experience, backed up by a review of the literature, indicates that milder hypomanic symptoms also occur in the early puerperium. Although these symptoms may often be regarded as clinically insignificant, there is evidence that the experience of minor puerperal elation may be a predictor of later postpartum depression. In addition, studying mild puerperal high mood may provide insights into the pathophysiology of more severe puerperal mania and psychosis. This paper critically reviews the literature on milder forms of high mood occurring in the puerperium and discusses the potential clinical and research significance of 'the highs'.

Bipolar Disorder↗